Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 31  •  04:00PM ET
81.96
Dollar change
-0.51
Percentage change
-0.62
%
IndexS&P 500 P/E43.74 EPS (ttm)1.87 Insider Own0.65% Shs Outstand195.90M Perf Week-1.11%
Market Cap16.06B Forward P/E16.58 EPS next Y4.94 Insider Trans2.74% Shs Float194.70M Perf Month5.88%
Enterprise Value18.74B PEG1.72 EPS next Q1.03 Inst Own105.85% Short Float3.79% Perf Quarter20.41%
Income374.90M P/S3.92 EPS this Y9.84% Inst Trans2.00% Short Ratio2.62 Perf Half Y12.24%
Sales4.09B P/B1.95 EPS next Y9.21% ROA3.03% Short Interest7.37M Perf YTD-10.85%
Book/sh42.06 P/C145.23 EPS next 5Y9.64% ROE4.59% 52W High100.24 -18.24% Perf Year-11.24%
Cash/sh0.56 P/FCF37.04 EPS past 3/5Y-1.15% 9.30% ROIC3.43% 52W Low61.78 32.68% Perf 3Y-1.47%
Dividend Est.- EV/EBITDA17.67 Sales past 3/5Y7.35% 10.98% Gross Margin60.67% Volatility1.11% 2.45% Perf 5Y-7.91%
Dividend TTM- EV/Sales4.58 EPS Y/Y TTM-4.47% Oper. Margin16.69% ATR (14)1.78 Perf 10Y144.02%
Dividend Ex-DateJul 26, 2023 Quick Ratio1.13 Sales Y/Y TTM5.06% Profit Margin9.16% RSI (14)59.77 Recom2.26
Dividend Gr. 3/5Y- - Current Ratio1.89 EPS Q/Q-26.90% SMA200.89% Beta1.03 Target Price89.93
Payout0.00% Debt/Eq0.34 Sales Q/Q4.60% SMA507.62% Rel Volume0.37 Prev Close82.47
Employees15000 LT Debt/Eq0.33 EarningsDec 04 AMC SMA20010.03% Avg Volume2.81M Price81.96
IPOJan 21, 1983 Option/ShortYes / Yes EPS/Sales Surpr.3.30% 0.42% Trades Volume1,051,806 Change-0.62%
Date Action Analyst Rating Change Price Target Change
Nov-13-25Downgrade Wells Fargo Overweight → Equal Weight $72
Oct-13-25Initiated Barclays Overweight $85
Oct-01-25Initiated Goldman Sell $64
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Aug-29-24Reiterated Piper Sandler Overweight $115 → $120
Jul-16-24Upgrade Jefferies Hold → Buy $107 → $115
Mar-19-24Upgrade Redburn Atlantic Neutral → Buy $125
Dec-31-25 07:36AM
Dec-30-25 02:04PM
07:33AM
Dec-29-25 04:15PM
Dec-26-25 11:40AM
08:00AM Loading…
Dec-23-25 08:00AM
Dec-22-25 12:12PM
Dec-19-25 09:55AM
Dec-16-25 11:05PM
11:37AM
Dec-12-25 09:50AM
Dec-11-25 07:34AM
12:31AM
Dec-10-25 11:40AM
Dec-08-25 09:40AM
09:15AM Loading…
09:15AM
Dec-05-25 11:11AM
11:02AM
09:11AM
07:36AM
02:46AM
12:31AM
12:02AM
Dec-04-25 06:30PM
05:25PM
04:45PM
04:20PM
04:15PM
Dec-03-25 05:15PM
12:45PM
10:04PM Loading…
Dec-02-25 10:04PM
Dec-01-25 09:15AM
06:11AM
Nov-30-25 07:27AM
07:27AM
Nov-27-25 10:00AM
Nov-23-25 11:36PM
Nov-21-25 06:36PM
Nov-19-25 06:38AM
Nov-14-25 05:10PM
Nov-13-25 05:20PM
09:45AM
09:10AM
Nov-06-25 07:40AM
Nov-05-25 06:30PM
Nov-04-25 04:15PM
Nov-03-25 12:00PM
Oct-31-25 10:23AM
Oct-28-25 01:54AM
Oct-21-25 09:24AM
Oct-20-25 09:34AM
08:21AM
07:41AM
07:25AM
Oct-19-25 08:00PM
Oct-16-25 09:40AM
Oct-01-25 11:01AM
Sep-26-25 11:30AM
12:39AM
Sep-22-25 09:46AM
Sep-19-25 01:55AM
Sep-18-25 11:42AM
Sep-17-25 04:15PM
Sep-15-25 09:40AM
Sep-09-25 12:02AM
Sep-03-25 01:31AM
Sep-02-25 03:30PM
Sep-01-25 09:15AM
Aug-31-25 11:34PM
Aug-29-25 09:47AM
09:40AM
Aug-28-25 05:28PM
04:25PM
04:05PM
11:48AM
11:30AM
11:20AM
11:12AM
09:50AM
09:39AM
05:46AM
05:10AM
03:06AM
Aug-27-25 06:00PM
05:25PM
04:49PM
04:15PM
Aug-26-25 06:42PM
11:40AM
09:55AM
08:22AM
Aug-25-25 11:02PM
09:51AM
Aug-22-25 09:15AM
Aug-20-25 10:00AM
Aug-19-25 08:50AM
Aug-14-25 05:30PM
04:15PM
Aug-12-25 10:58AM
08:13AM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lucchese Cynthia LDirectorDec 22 '25Buy84.061,784149,9639,445Dec 23 04:08 PM
Rivas MariaDirectorDec 18 '25Buy82.131,00082,13011,141Dec 19 04:18 PM
Kurzius Lawrence ErikDirectorDec 17 '25Buy82.502,000165,0007,777Dec 17 05:06 PM
Sheffield Holly RPresident, CSIDec 16 '25Buy80.751,23099,32239,052Dec 16 06:36 PM
White Albert G IIIPresident & CEODec 16 '25Buy80.8010,000808,000236,151Dec 16 06:36 PM
Kurzius Lawrence ErikDirectorSep 29 '25Buy68.392,000136,7805,777Sep 29 08:36 PM
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM
KOZY WILLIAM ADirectorApr 01 '25Option Exercise0.002,857031,149Apr 03 04:09 PM
WEISS ROBERT SDirectorApr 01 '25Option Exercise0.002,9930288,945Apr 03 04:09 PM
Rivas MariaDirectorApr 01 '25Option Exercise0.002,72102,721Apr 03 04:08 PM
MADDEN TERESA SDirectorApr 01 '25Option Exercise0.002,721012,357Apr 03 04:08 PM
Lucchese Cynthia LDirectorApr 01 '25Option Exercise0.002,72107,661Apr 03 04:07 PM
Kurzius Lawrence ErikDirectorApr 01 '25Option Exercise0.002,72103,777Apr 03 04:07 PM
Jay ColleenDirectorApr 01 '25Option Exercise0.002,721029,521Apr 03 04:06 PM
Ricupati AgostinoSVP & CAOApr 01 '25Option Exercise0.002,07609,044Apr 03 04:06 PM
McBride Daniel GEVP & Chief Operating OfficerFeb 01 '25Option Exercise0.0022,777071,687Feb 04 04:25 PM
White Albert G IIIPresident & CEOFeb 01 '25Option Exercise0.0084,2640258,941Feb 04 04:25 PM
Andrews Brian GEVP, CFO & TreasurerFeb 01 '25Option Exercise0.0016,850023,464Feb 04 04:24 PM
Sheffield Holly RPresident, CSIFeb 01 '25Option Exercise0.0017,309045,843Feb 04 04:24 PM
White Albert G IIIPresident & CEOJan 08 '25Option Exercise0.0018,3400183,613Jan 10 04:12 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '25Option Exercise0.0013,328023,763Jan 10 04:12 PM
Sheffield Holly RPresident, CSIJan 08 '25Option Exercise0.004,900030,898Jan 10 04:11 PM
Ricupati AgostinoSVP & CAOJan 08 '25Option Exercise0.004,47209,328Jan 10 04:11 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '25Option Exercise0.008,728053,424Jan 10 04:11 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '25Option Exercise0.006,420013,034Jan 10 04:10 PM
Khadder NicholasVP, General Counsel & Corp SecJan 08 '25Option Exercise0.003,49204,369Jan 10 04:10 PM
Last Close
Dec 31  •  04:00PM ET
45.30
Dollar change
-0.62
Percentage change
-1.35
%
OMCL Omnicell, Inc daily Stock Chart
IndexRUT P/E106.24 EPS (ttm)0.43 Insider Own3.00% Shs Outstand44.88M Perf Week-0.59%
Market Cap2.03B Forward P/E24.57 EPS next Y1.84 Insider Trans-3.02% Shs Float43.53M Perf Month25.42%
Enterprise Value2.01B PEG3.38 EPS next Q0.49 Inst Own101.55% Short Float6.28% Perf Quarter51.20%
Income19.92M P/S1.73 EPS this Y0.00% Inst Trans-4.29% Short Ratio5.69 Perf Half Y52.01%
Sales1.18B P/B1.67 EPS next Y7.82% ROA0.94% Short Interest2.74M Perf YTD1.75%
Book/sh27.21 P/C9.02 EPS next 5Y7.26% ROE1.62% 52W High47.69 -5.01% Perf Year2.81%
Cash/sh5.02 P/FCF18.24 EPS past 3/5Y-44.95% -28.29% ROIC1.41% 52W Low22.66 99.91% Perf 3Y-6.48%
Dividend Est.- EV/EBITDA19.08 Sales past 3/5Y-0.59% 4.39% Gross Margin43.82% Volatility1.69% 4.04% Perf 5Y-61.83%
Dividend TTM- EV/Sales1.71 EPS Y/Y TTM210.53% Oper. Margin1.57% ATR (14)1.39 Perf 10Y57.51%
Dividend Ex-Date- Quick Ratio1.17 Sales Y/Y TTM10.67% Profit Margin1.69% RSI (14)64.88 Recom1.75
Dividend Gr. 3/5Y- - Current Ratio1.41 EPS Q/Q-35.99% SMA202.21% Beta0.79 Target Price51.50
Payout0.00% Debt/Eq0.17 Sales Q/Q9.99% SMA5018.09% Rel Volume0.72 Prev Close45.92
Employees3670 LT Debt/Eq0.16 EarningsOct 30 BMO SMA20039.20% Avg Volume480.43K Price45.30
IPOAug 07, 2001 Option/ShortYes / Yes EPS/Sales Surpr.40.69% 5.09% Trades Volume346,282 Change-1.35%
Date Action Analyst Rating Change Price Target Change
May-14-25Upgrade Wells Fargo Equal Weight → Overweight $35
Oct-31-24Downgrade BofA Securities Buy → Neutral $44 → $57
Aug-02-24Upgrade Barclays Underweight → Equal Weight $26 → $39
Jan-03-24Initiated Barclays Underweight $33
Nov-03-23Upgrade Wells Fargo Underweight → Equal Weight $39 → $28
Nov-03-23Upgrade Piper Sandler Neutral → Overweight $70 → $39
Nov-03-23Downgrade BTIG Research Buy → Neutral
Oct-11-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-26-23Reiterated Wells Fargo Underweight $56 → $39
Aug-02-23Downgrade Piper Sandler Overweight → Neutral $66 → $70
Dec-31-25 10:30AM
Dec-29-25 09:48AM
Dec-23-25 12:35PM
Dec-17-25 07:58AM
Dec-16-25 10:00AM
05:43AM Loading…
05:43AM
Dec-15-25 09:12AM
Dec-10-25 08:34AM
08:31AM
Dec-09-25 07:28AM
07:27AM
07:26AM
Dec-08-25 11:40AM
08:00AM
07:56AM
11:34PM Loading…
Dec-07-25 11:34PM
Dec-05-25 08:48AM
08:31AM
Dec-04-25 11:30AM
Dec-03-25 11:30AM
Nov-27-25 09:55AM
Nov-20-25 04:01PM
11:40AM
Nov-10-25 09:55AM
Nov-04-25 11:40AM
09:21AM
Nov-03-25 12:20PM
11:40AM
Oct-30-25 06:45PM
04:31PM
02:35PM Loading…
02:35PM
07:45AM
06:54AM
06:40AM
06:30AM
Oct-28-25 11:15PM
Oct-27-25 10:00AM
Oct-24-25 09:55AM
Oct-23-25 10:00AM
09:40AM
Oct-21-25 10:46PM
05:19AM
Oct-17-25 11:40AM
Oct-14-25 03:00PM
Oct-07-25 09:40AM
08:23AM
Oct-06-25 04:01PM
Oct-02-25 12:43AM
Oct-01-25 11:40AM
09:30AM
Sep-30-25 10:05AM
Sep-18-25 09:40AM
Sep-15-25 11:40AM
Sep-12-25 03:35AM
Sep-11-25 03:00PM
09:55AM
Sep-05-25 12:34AM
Sep-03-25 11:30AM
Sep-01-25 12:02AM
Aug-27-25 11:38PM
Aug-26-25 12:20PM
09:55AM
Aug-25-25 04:05PM
Aug-14-25 09:34AM
Aug-13-25 12:04AM
Aug-12-25 11:50PM
Aug-01-25 09:55AM
Jul-31-25 07:45AM
06:59AM
06:43AM
06:30AM
Jul-30-25 01:09PM
11:40AM
Jul-29-25 11:04PM
Jul-28-25 10:00AM
Jul-24-25 10:00AM
08:00AM
12:33AM
Jul-21-25 12:20PM
Jul-18-25 08:34AM
Jul-15-25 04:05PM
Jul-14-25 04:01PM
Jul-09-25 12:13PM
Jul-07-25 12:01AM
Jul-03-25 04:08AM
Jun-26-25 05:58PM
Jun-16-25 11:38PM
Jun-13-25 08:42AM
Jun-06-25 09:02AM
Jun-05-25 11:31AM
May-31-25 05:59AM
May-22-25 01:25PM
08:30AM
May-19-25 08:33AM
May-15-25 08:55AM
May-14-25 04:01PM
08:30AM
May-07-25 01:25PM
09:20AM
03:07AM
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERDec 16 '25Sale43.3027812,03797,780Dec 17 04:05 PM
Manley Corey JOfficerDec 16 '25Proposed Sale43.3027812,037Dec 16 09:48 AM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERDec 03 '25Sale39.906,106243,62998,282Dec 05 04:05 PM
Manley Corey JOfficerDec 03 '25Proposed Sale39.906,106243,629Dec 03 04:39 PM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEODec 01 '25Option Exercise27.7028,250782,525414,898Dec 03 04:05 PM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEODec 01 '25Sale35.9728,2501,016,093386,648Dec 03 04:05 PM
Randall LippsOfficerDec 01 '25Proposed Sale35.9728,2501,016,092Dec 01 01:12 PM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERNov 17 '25Sale34.903,473121,208104,388Nov 18 04:13 PM
Manley Corey JOfficerNov 17 '25Proposed Sale34.903,473121,208Nov 17 10:36 AM
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICERSep 12 '25Sale33.253,880129,010110,653Sep 16 04:09 PM
Manley Corey JOfficerSep 12 '25Proposed Sale33.253,880129,010Sep 12 11:36 AM
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEOMar 14 '25Buy33.1310,561349,874333,610Mar 18 04:13 PM